Tag: Prostate cancer

Jeffrey Smith

Associate Professor & Director, Carleton Mass Spectrometry Centre (CMSC), Department of Chemistry, Carleton University Associate Professor, Institute of Biochemistry, Carleton University   Full Biography   Cancers of Interest Blood Bone Breast Colorectal Liver Ovarian Pancreatic Prostate Skin Soft Tissue Sarcoma   Projects at BioCanRx Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral… Read more »

Sachdev Sidhu

Professor, Donnelly Centre, University of Toronto Senior Investigator, Ontario Institute for Cancer Research (OICR)   Full Biography   Cancers of Interest Bladder, Blood, Brain, Breast, Colorectal, Gastric, Head and Neck, Kidney, Liver, Lung, Neuroblastoma, Ovarian, Pancreatic, Prostate, Skin   Research and clinical approaches The Sidhu lab studies the relationships between protein structure and function, using… Read more »

Harman Sekhon

Full Professor, Director of Cytopathology, University of Ottawa   Full Biography   Cancers of Interest Lung Ovarian Prostate   Projects at BioCanRx Interrogation of Biomarkers in Patient Samples from a Phase Ib Trial of the Immune Checkpoint Inhibitor, Avelumab, in Combination with SMAC Mimetic Debio1143

Brad Nelson

Scientific Co-Director, BC Cancer Immunotherapy Program (Deeley Research Centre) Professor of Biochemistry/Microbiology, University of Victoria Professor of Medical Genetics, University of British Columbia   Full Biography   Projects at BioCanRx Enabling a Phase I/II Multicenter Clinical Trial of a Novel Single Domain (sd)CD-22-specific Camelid-derived Chimeric Antigen Receptor (CAR) T-cell Therapy   Interrogation of Biomarkers in… Read more »

Brian Lichty

PhD, Associate Professor, Pathology and Molecular Medicine, McMaster   Full Biography   Cancers of Interest Breast Cervical Gynecological Lung Prostate Skin   Projects at BioCanRx Development of a Virally Programmed Exosome-based Cancer Vaccine Platform   COMBINING ONCOLYTIC VACCINE THERAPY WITH ADOPTIVE CELL THERAPY TO TARGET CANCERS EXPRESSING MAGE-A3   A Phase 1/1b, Multicenter, Open-label Trial… Read more »

Aly-Khan Lalani

Assistant Professor, Oncology, McMaster University   Full Biography   Cancers of Interest Bladder Gastrointestinal Stromal Tumours (GIST) Genitourinary Kidney Prostate Soft Tissue Sarcoma Testicular   Projects at BioCanRx   Phase II CYTOSHRINK Trial: Cytoreductive Stereotactic Hypofractionated Radiotherapy with Combination Ipilimumab and Nivolumab for Metastatic Kidney Cancer

Steven Jones

Canada Research Chair in Computational Genomics, University of British Columbia Professor, Medical Genetics/ Genetics Graduate Program, University of British Columbia Director Bioinformatics, Genome BC Bioinformatics Platform, Genome BC Founding Director, CIHR/MSFHR Bioinformatics Training Program Director, Bioinformatics Graduate Program, University of British Columbia   Full Biography   Cancers of Interest Bladder, Blood, Bone, Brain, Breast, Cervical,… Read more »

Naoto Hirano

Senior Scientist, Princess Margaret Cancer Centre   Full Biography   Cancers of Interest Blood, Breast, Lung, Ovarian, Pancreatic, Prostate, Skin, Soft Tissue Sarcoma   Research Interests and Clinical Approach Dr. Hirano‚Äôs research team is particularly interested in understanding how the interactions between T cells and antigen-presenting cells affect priming, expansion, persistence and differentiation of T… Read more »

Jean-Simon Diallo

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute Associate Scientist, Faculty of Medicine, University of Ottawa   Full Biography   Cancers of Interest Sarcoma Prostate Breast   Research Interests and Clinical Approach Oncolytic Virotherapy Viral sensitizers Combination Immunotherapy   Projects at BioCanRx Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral Sensitizer… Read more »

Gregory Dekaban

Robarts Scientist and Professor, Robarts Research Institute   Full Biography   Cancers of Interest Blood Prostate   Projects at BioCanRx In vivo human therapeutic cell tracking using a [19F]-perfluorocarbon cellular MRI contrast agent: Phase I feasibility and preliminary safety trial